114 related articles for article (PubMed ID: 8450933)
1. Differential vulnerability, connectivity, and cell typology.
Morrison JH
Neurobiol Aging; 1993; 14(1):51-4; discussion 55-6. PubMed ID: 8450933
[No Abstract] [Full Text] [Related]
2. Cortical connections and the pathology of Alzheimer's disease.
Pearson RC
Neurodegeneration; 1996 Dec; 5(4):429-34. PubMed ID: 9117558
[TBL] [Abstract][Full Text] [Related]
3. The role of cortical connectivity in Alzheimer's disease pathogenesis: a review and model system.
De Lacoste MC; White CL
Neurobiol Aging; 1993; 14(1):1-16. PubMed ID: 8450928
[TBL] [Abstract][Full Text] [Related]
4. From the bridges of Konigsberg to the fields of Alzheimer: connecting the dots.
Petrella JR; Doraiswamy PM
Neurology; 2013 Apr; 80(15):1360-2. PubMed ID: 23486887
[No Abstract] [Full Text] [Related]
5. Alzheimer plaques and cortical cholinergic innervation.
Mesulam MM
Neuroscience; 1986; 17(1):275-6. PubMed ID: 3960313
[No Abstract] [Full Text] [Related]
6. Selective vulnerability of corticocortical and hippocampal circuits in aging and Alzheimer's disease.
Morrison JH; Hof PR
Prog Brain Res; 2002; 136():467-86. PubMed ID: 12143403
[TBL] [Abstract][Full Text] [Related]
7. Vestibular loss as a contributor to Alzheimer's disease.
Previc FH
Med Hypotheses; 2013 Apr; 80(4):360-7. PubMed ID: 23375669
[TBL] [Abstract][Full Text] [Related]
8. Neural substrates of cognitive and behavioral deficits in atypical Alzheimer's disease.
von Gunten A; Bouras C; Kövari E; Giannakopoulos P; Hof PR
Brain Res Rev; 2006 Aug; 51(2):176-211. PubMed ID: 16413610
[TBL] [Abstract][Full Text] [Related]
9. Hippocampal-sparing Alzheimer's disease presenting as corticobasal syndrome.
Malkani RG; Dickson DW; Simuni T
Parkinsonism Relat Disord; 2012 Jun; 18(5):683-5. PubMed ID: 22172552
[No Abstract] [Full Text] [Related]
10. The systems-level organization of cholinergic innervation in the human cerebral cortex and its alterations in Alzheimer's disease.
Mesulam MM
Prog Brain Res; 1996; 109():285-97. PubMed ID: 9009717
[No Abstract] [Full Text] [Related]
11. Alzheimer's disease and Abeta toxicity: from top to bottom.
Small DH; Mok SS; Bornstein JC
Nat Rev Neurosci; 2001 Aug; 2(8):595-8. PubMed ID: 11484003
[No Abstract] [Full Text] [Related]
12. Oligodendrocyte degeneration in AD.
Whitman GT; Cotman CW
Neurobiol Aging; 2004 Jan; 25(1):33-6. PubMed ID: 14675727
[No Abstract] [Full Text] [Related]
13. Alterations of signal transduction in the lesioned entorhinal-hippocampal system: a mini-review on Alzheimer's disease-related changes and experimental data.
Ohm TG
Hippocampus; 1993; 3 Spec No():131-8. PubMed ID: 8287091
[No Abstract] [Full Text] [Related]
14. Age-related changes in the human forebrain.
Scheibel AB
Neurosci Res Program Bull; 1982 Apr; 20(4):577-83. PubMed ID: 7121843
[No Abstract] [Full Text] [Related]
15. Life and death of neurons in the aging cerebral cortex.
Morrison JH; Hof PR
Int Rev Neurobiol; 2007; 81():41-57. PubMed ID: 17433917
[TBL] [Abstract][Full Text] [Related]
16. Distinctive Resting State Network Disruptions Among Alzheimer's Disease, Subcortical Vascular Dementia, and Mixed Dementia Patients.
Kim HJ; Cha J; Lee JM; Shin JS; Jung NY; Kim YJ; Choe YS; Lee KH; Kim ST; Kim JS; Lee JH; Na DL; Seo SW
J Alzheimers Dis; 2016; 50(3):709-18. PubMed ID: 26757039
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical localization of neprilysin in the human cerebral cortex: inverse association with vulnerability to amyloid beta-protein (Abeta) deposition.
Akiyama H; Kondo H; Ikeda K; Kato M; McGeer PL
Brain Res; 2001 Jun; 902(2):277-81. PubMed ID: 11384622
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's disease in a patient with posterior cortical atrophy.
Berthier ML; Leiguarda R; Starkstein SE; Sevlever G; Taratuto AL
J Neurol Neurosurg Psychiatry; 1991 Dec; 54(12):1110-1. PubMed ID: 1783928
[TBL] [Abstract][Full Text] [Related]
19. Education modifies the association of amyloid but not tangles with cognitive function.
Bennett DA; Schneider JA; Wilson RS; Bienias JL; Arnold SE
Neurology; 2005 Sep; 65(6):953-5. PubMed ID: 16186546
[TBL] [Abstract][Full Text] [Related]
20. A direct demonstration of the perforant pathway terminal zone in Alzheimer's disease using the monoclonal antibody Alz-50.
Hyman BT; Kromer LJ; Van Hoesen GW
Brain Res; 1988 May; 450(1-2):392-7. PubMed ID: 3401721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
